Could a common diabetes drug ease endometriosis pain?
NCT ID NCT06611501
First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This pilot study tests whether metformin, a drug typically used for diabetes, can reduce pelvic pain in young women with endometriosis. Fourteen participants will take either metformin or a placebo daily for six months and track their symptoms. The goal is to see if this non-hormonal approach can improve pain and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Metformin
- What this could lead to
- If it works, this could offer a new non-hormonal option to ease pelvic pain in young women with endometriosis.
- What could go wrong
- This is a very small early-phase trial with only 14 participants. It may not show a clear benefit over placebo, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can yoga ease the pain of endometriosis after surgery?
- Building a biological treasure trove to decode Women's health mysteries
- Gaming for health: could a video game empower endometriosis patients?
- Can a new formulation of an endometriosis drug match the standard?
- Can a glowing dye reveal a Woman's fertility after ovarian cyst surgery?
- Can we predict endometriosis recurrence and fertility outcomes?